Table 2.
Neurosteroid Levels (median; ng/g) in Temporal Cortex in Cognitively Intact Control Subjects and Patients with Alzheimer’s Disease.
| n | Min | Q1 | Med | Q3 | Max | P-value | |
|---|---|---|---|---|---|---|---|
| Allopregnanolone | 0.0002 | ||||||
| Alzheimer's disease | 40 | 0.477 | 1.954 | 2.681 | 3.96 | 16.84 | |
| Control | 41 | 0.266 | 3.896 | 5.644 | 10.37 | 32.11 | |
| Pregnenolone | 0.022 | ||||||
| Alzheimer's disease | 40 | 3.184 | 12.32 | 22.24 | 52.49 | 291.2 | |
| Control | 41 | 2.148 | 6.089 | 10.24 | 27.91 | 218.2 | |
| DHEA | 0.0185 | ||||||
| Alzheimer's disease | 40 | 0.87 | 2.332 | 4.751 | 7.523 | 40.31 | |
| Control | 41 | 0.103 | 1.625 | 2.232 | 5.409 | 42.51 |
Min, minimum, Q1, lower quartile; Med; median; Q3, upper quartile; Max, maximum.
p<05, Mann-Whitney U test statistic